Erratum
Literature Information
Publication Date
DOI
10.1039/AN936610253A
Impact Factor
4.616
Authors
View Original
Abstract
The first page of this article is displayed as the abstract.
Related Literature
Copper-catalyzed redox-neutral regioselective chlorosulfonylation of vinylarenes
Lixia Liu, Chengming Wang
2021-06-16
Communication
DOI: 10.1039/D1RE00188D
Reconfiguring workup steps in multi-cycle extractive bioconversion for sustainable fatty alcohol production: a process engineering approach
Supacha Buttranon, Juthamas Jaroensuk, Patchara Chaichol, Pimchai Chaiyen
2021-10-15
Paper
DOI: 10.1039/D1RE00394A
Kinetics of furfural electrochemical hydrogenation and hydrogenolysis in acidic media on copper
Andrew S. May
2021-08-16
Paper
DOI: 10.1039/D1RE00216C
Tailoring of a catalyst La0.8Ce0.1Ni0.4Ti0.6O3−δ interlayer via in situ exsolution for a catalytic membrane reactor
Ping Luo, Zhi Xu, Qiankun Zheng, Jinkun Tan, Zhicheng Zhang, Zhengkun Liu, Guangru Zhang, Wanqin Jin
2021-04-17
Paper
DOI: 10.1039/D1RE00103E
A novel LaFeO3 catalyst synthesized from sodium diethylenetriamine pentamethylene phosphonate for degradation of diclofenac through peroxymonosulfate activation: degradation pathways and mechanism study
Shuaiqi Ning, Shuai Mao, Chun Liu, Mingzhu Xia, Fengyun Wang
2021-09-14
Paper
DOI: 10.1039/D1RE00259G
Construction of supramolecular laccase enzymes and understanding of catalytic dye degradation using multispectral and molecular docking approaches
Qingteng Zhou, Kaijie Ni, Francesca M. Kerton
2021-07-26
Paper
DOI: 10.1039/D1RE00111F
An activated carbon fiber supported Fe2O3@bismuth carbonate heterojunction for enhanced visible light degradation of emerging pharmaceutical pollutants
Prasenjit Kar, Komal Shukla, Pratyush Jain
2021-08-31
Paper
DOI: 10.1039/D1RE00250C
Multi-size control of homogeneous explosives by coaxial microfluidics
Jinyu Shi, Shuangfei Zhao, Hanyu Jiang, Siyu Xu, Fengqi Zhao, Ruiqi Shen, Yinghua Ye, Peng Zhu
2021-09-17
Paper
DOI: 10.1039/D1RE00328C
You might also like
Compound Q&A
What is the market or research trend for N-(4-Methoxybenzyl)-2-pyridinamine (CAS: 52818-63-0)?
N-(4-Methoxybenzyl)-2-pyridinamine (CAS: 52818-63-0) is increasingly being used ...
52818-63-0N-(4-Methoxybenzyl)-...
Compound Q&A
What precautions should be taken when handling Ethyl 4-(2-chlorophenyl)-1,3-thiazole-2-carboxylate (CAS: 1050507-06-6)?
When handling Ethyl 4-(2-chlorophenyl)-1,3-thiazole-2-carboxylate, appropriate p...
1050507-06-6Ethyl 4-(2-chlorophe...
Compound Q&A
What regulatory guidelines apply to diethyldiselane (CAS: 628-39-7)?
Diethyldiselane (CAS: 628-39-7) is classified under the Globally Harmonized Syst...
628-39-7Diethyldiselane
Compound Q&A
What is the market or research trend for oxocopper (CAS: 12053-18-8)?
The market for oxocopper (CAS: 12053-18-8) is primarily driven by its use in cat...
12053-18-8oxocopper; oxo-(oxoc...
Compound Q&A
What is the market or research trend for 5-{[(2-Methyl-2-propanyl)oxy]carbonyl}-5-azaspiro[2.4]heptane-7-carboxylic acid?
The market for 5-{[(2-Methyl-2-propanyl)oxy]carbonyl}-5-azaspiro[2.4]heptane-7-c...
1268519-54-55-{[(2-Methyl-2-prop...
Compound Q&A
What is 2-(1-Pyrrolidinyl)-4-pyridinamine (CAS: 35981-63-6)?
2-(1-Pyrrolidinyl)-4-pyridinamine is a chemical compound with the CAS number 359...
35981-63-62-(1-Pyrrolidinyl)-4...
Compound Q&A
What are the physical and chemical properties of 2-(3-Pyridinyl)-1-azabicyclo[2.2.2]octane (CAS: 91556-75-1)?
2-(3-Pyridinyl)-1-azabicyclo[2.2.2]octane (CAS: 91556-75-1) is a crystalline sol...
91556-75-12-(3-Pyridinyl)-1-az...
Compound Q&A
How is (S)-Alpha-allyl-proline hydrochloride (CAS: 129704-91-2) typically synthesized?
(S)-Alpha-allyl-proline hydrochloride is usually synthesized via a Wittig reacti...
129704-91-2(S)-Alpha-allyl-prol...
Compound Q&A
What is 3-Methyl-1,2-oxazole-5-carboxylic acid (CAS: 4857-42-5)?
3-Methyl-1,2-oxazole-5-carboxylic acid (CAS: 4857-42-5) is an organic compound w...
4857-42-53-Methyl-1,2-oxazole...
Compound Q&A
How is Lys-SMCC-DM1 (CAS: 1281816-04-3) typically synthesized?
Lys-SMCC-DM1 is synthesized via a multi-step process involving the coupling of S...
1281816-04-3Lys-SMCC-DM1
Source Journal
Analyst
CiteScore:
7.8
Self-citation Rate:
5.6%
Articles per Year:
653
Analyst publishes analytical and bioanalytical research that reports premier fundamental discoveries and inventions, and the applications of those discoveries, unconfined by traditional discipline barriers.
Recommended Compounds
![N-{15-[(2,5-Dioxo-1-pyrrolidinyl)oxy]-15-oxo-3,6,9,12-tetraoxapentadec-1-yl}-2-(2-propyn-1-yloxy)acetamide structure](https://static.chemtradehub.com/structs/210/2101206-92-0-2eb5.webp "N-{15-[(2,5-Dioxo-1-pyrrolidinyl)oxy]-15-oxo-3,6,9,12-tetraoxapentadec-1-yl}-2-(2-propyn-1-yloxy)acetamide structure")
N-{15-[(2,5-Dioxo-1-pyrrolidinyl)oxy]-15-oxo-3,6,9,12-tetraoxapentadec-1-yl}-2-(2-propyn-1-yloxy)acetamide
CAS Number:
2101206-92-0
Molecular Formula:
C20H30N2O10
(3alpha,5beta,6alpha,7alpha)-6-Ethylcholane-3,7,24-triol
CAS Number:
1537866-49-1
Molecular Formula:
C26H46O3
![1,10-bis(3,5-dimethylphenyl)-12-hydroxy-4,5,6,7-tetrahydroiindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocine 12-oxide structure](https://static.chemtradehub.com/structs/141/1412439-82-7-b9a9.webp "1,10-bis(3,5-dimethylphenyl)-12-hydroxy-4,5,6,7-tetrahydroiindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocine 12-oxide structure")
1,10-bis(3,5-dimethylphenyl)-12-hydroxy-4,5,6,7-tetrahydroiindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocine 12-oxide
CAS Number:
1412439-82-7
Molecular Formula:
C33H31O4P
![1-oxaspiro[4.4]nonan-6-one structure](https://static.chemtradehub.com/structs/134/134179-01-4-e051.webp "1-oxaspiro[4.4]nonan-6-one structure")
Recommended Suppliers
Disclaimer
This page provides academic journal information for reference and research purposes only. We are not affiliated with any journal publishers and do not handle publication submissions. For publication-related inquiries, please contact the respective journal publishers directly.
If you notice any inaccuracies in the information displayed, please contact us at support@chemtradehub.com. We will promptly review and address your concerns.